In apparent contrast to such findings, in the current study we describe that the cAMP elevating agent forskolin, in a PKA-mediated mechanism, causes cell death induction accompanied by BCL-2 down regulation when used in combination with the H3K27me2/3-specific demethylases GSKJ4 inhibitor in U937 leukemia cells. This evidence concerns the gene BCL2 and leukemia.